Latest News & Features
Big Pharma
Pharmaceutical company GSK has announced to shareholders that its chief executive Sir Andrew Witty will be retiring from his role in 2017. 17 March 2016
Americas
Patent owners and petitioners in the life sciences industry who raise arguments surrounding commercial success during PTAB trials face substantive and procedural roadblocks, argue Christopher Jagoe and James McConnell of Kirkland & Ellis. 17 March 2016
Americas
The Patent Trial and Appeal Board has instituted trials on four patents owned by Acorda Therapeutics following challenges from the Coalition for Affordable Drugs and hedge fund manager Kyle Bass. 16 March 2016
Americas
Law firm Proskauer Rose has expanded its life sciences patent practice by hiring Fangli Chen as a partner and Daniel Klein as a senior patent counsel. 16 March 2016
Asia
Activist organisation Médecins Sans Frontières has challenged Pfizer’s patent application covering the pneumococcal conjugate vaccine on the grounds that it is obvious. 15 March 2016
Asia
A Switzerland-based drug licensing agency has warned that counterfeit packs of hepatitis C drug Harvoni have been imported into Switzerland. 14 March 2016
Americas
The Patent Trial and Appeal Board has rejected three inter partes reviews filed by Kyle Bass’s organisation the Coalition for Affordable Drugs. 11 March 2016
Americas
The US Patent and Trademark Office has opened proceedings to determine who owns the rights to the CRISPR/Cas9 technology. 11 March 2016
Americas
The US Food and Drug Administration has appointed Stephen Ostroff to deputy commissioner for food and veterinary medicine. 10 March 2016
Big Pharma
Pharmaceutical company AstraZeneca agreed a deal with ProStrakan Group centring on the rights to the Moventig (naloxegol) drug in Europe. 9 March 2016